These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 19900214)

  • 1. Identification of microRNA profiles in docetaxel-resistant human non-small cell lung carcinoma cells (SPC-A1).
    Rui W; Bing F; Hai-Zhu S; Wei D; Long-Bang C
    J Cell Mol Med; 2010 Jan; 14(1-2):206-14. PubMed ID: 19900214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-200b reverses chemoresistance of docetaxel-resistant human lung adenocarcinoma cells by targeting E2F3.
    Feng B; Wang R; Song HZ; Chen LB
    Cancer; 2012 Jul; 118(13):3365-76. PubMed ID: 22139708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-148b reverses cisplatin-resistance in non-small cell cancer cells via negatively regulating DNA (cytosine-5)-methyltransferase 1(DNMT1) expression.
    Sui C; Meng F; Li Y; Jiang Y
    J Transl Med; 2015 Apr; 13():132. PubMed ID: 25927928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-100 resensitizes docetaxel-resistant human lung adenocarcinoma cells (SPC-A1) to docetaxel by targeting Plk1.
    Feng B; Wang R; Chen LB
    Cancer Lett; 2012 Apr; 317(2):184-91. PubMed ID: 22120675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-222 and miR-29a contribute to the drug-resistance of breast cancer cells.
    Zhong S; Li W; Chen Z; Xu J; Zhao J
    Gene; 2013 Nov; 531(1):8-14. PubMed ID: 23994196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nimotuzumab increases chemosensitivity of human lung adenocarcinoma cell lines to docetaxel.
    Song HZ; Yi J; Chen J; Chen LB
    Oncol Res; 2012; 20(1):39-47. PubMed ID: 23035364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of ING4 (inhibitor of growth 4) as a modulator of docetaxel sensitivity in human lung adenocarcinoma.
    Wang R; Huang J; Feng B; De W; Chen L
    Mol Med; 2012 Jul; 18(1):874-86. PubMed ID: 22460125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-138 negatively regulates non-small cell lung cancer cells through the interaction with cyclin D3.
    Han LP; Fu T; Lin Y; Miao JL; Jiang QF
    Tumour Biol; 2016 Jan; 37(1):291-8. PubMed ID: 26201895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-638 is a new biomarker for outcome prediction of non-small cell lung cancer patients receiving chemotherapy.
    Wang F; Lou JF; Cao Y; Shi XH; Wang P; Xu J; Xie EF; Xu T; Sun RH; Rao JY; Huang PW; Pan SY; Wang H
    Exp Mol Med; 2015 May; 47(5):e162. PubMed ID: 25952770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Docetaxel inhibits the proliferation of non-small-cell lung cancer cells via upregulation of microRNA-7 expression.
    He X; Li C; Wu X; Yang G
    Int J Clin Exp Pathol; 2015; 8(8):9072-80. PubMed ID: 26464649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiRNA-26a Contributes to the Acquisition of Malignant Behaviors of Doctaxel-Resistant Lung Adenocarcinoma Cells through Targeting EZH2.
    Chen J; Xu Y; Tao L; Pan Y; Zhang K; Wang R; Chen LB; Chu X
    Cell Physiol Biochem; 2017; 41(2):583-597. PubMed ID: 28214878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression Profiles of microRNAs in Drug-Resistant Non-Small Cell Lung Cancer Cell Lines Using microRNA Sequencing.
    Hu S; Yuan Y; Song Z; Yan D; Kong X
    Cell Physiol Biochem; 2018; 51(6):2509-2522. PubMed ID: 30557872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-219a-5p enhances cisplatin sensitivity of human non-small cell lung cancer by targeting FGF9.
    Rao C; Miao X; Zhao G; Zhang C; Shen H; Dong C; Yang M
    Biomed Pharmacother; 2019 Jun; 114():108662. PubMed ID: 30999114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-200b regulates autophagy associated with chemoresistance in human lung adenocarcinoma.
    Pan B; Feng B; Chen Y; Huang G; Wang R; Chen L; Song H
    Oncotarget; 2015 Oct; 6(32):32805-20. PubMed ID: 26416454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis.
    Guo L; Liu Y; Bai Y; Sun Y; Xiao F; Guo Y
    Eur J Cancer; 2010 Jun; 46(9):1692-702. PubMed ID: 20371173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miRNA-34a is associated with docetaxel resistance in human breast cancer cells.
    Kastl L; Brown I; Schofield AC
    Breast Cancer Res Treat; 2012 Jan; 131(2):445-54. PubMed ID: 21399894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-27b reverses docetaxel resistance of non-small cell lung carcinoma cells via targeting epithelial growth factor receptor.
    Chen S; Wang Q; Zhou XM; Zhu JP; Li T; Huang M
    Mol Med Rep; 2016 Jul; 14(1):949-54. PubMed ID: 27221512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Differential expression of serum miRNAs in patients with advanced non-small cell lung cancer treated by gifitinib before and after acquiring drug resistance].
    Huang Q; Li D
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 43(12):1288-1293. PubMed ID: 30643043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-451 induces epithelial-mesenchymal transition in docetaxel-resistant lung adenocarcinoma cells by targeting proto-oncogene c-Myc.
    Chen D; Huang J; Zhang K; Pan B; Chen J; De W; Wang R; Chen L
    Eur J Cancer; 2014 Nov; 50(17):3050-67. PubMed ID: 25310895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of miR-146a increases the sensitivity of non-small cell lung cancer to DDP by downregulating cyclin J.
    Shi L; Xu Z; Wu G; Chen X; Huang Y; Wang Y; Jiang W; Ke B
    BMC Cancer; 2017 Feb; 17(1):138. PubMed ID: 28202053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.